Literature DB >> 32656104

Utility of smear microscopy and GeneXpert for the detection of Mycobacterium tuberculosis in clinical samples.

Disha Arora1, Biranthabail Dhanashree2.   

Abstract

INTRODUCTION: Rapid identification of Mycobacterium tuberculosis (MTB), its resistance to rifampicin and differentiation of MTB from nontuberculous mycobacteria (NTM) is necessary in the management of mycobacterial diseases. Culture, the "gold standard" for the detection of MTB, is time consuming. In spite of its rapidity and low cost, smear microscopy has poor sensitivity for the detection of acid-fast bacilli (AFB). A real-time PCR based rapid diagnostic method like GeneXpert MTB/RIF assay can simultaneously detect M. tuberculosis and rifampicin (RIF) resistance. Hence, we aim to compare the performance of GeneXpert MTB/RIF assay with smear microscopy and culture.
METHODS: In this descriptive cross-sectional study, we compared the performance of GeneXpert in pulmonary (N=127) and extrapulmonary (N=48) clinical specimens with other diagnostic methods like culture, Auramine O (AO), and Ziehl Neelsen (ZN) staining. Rifampicin resistance was detected only by GeneXpert. Demographic data and clinical history of the subjects were collected from the patient's hospital records.
RESULTS: AO and ZN staining when compared with mycobacterial growth indicator (MGIT) culture showed the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 68.6, 95.7, 80, 92.4, 90.3% and 65.7, 95.7, 79.3, 91.8, 89.7%, respectively. The sensitivity, specificity, PPV, NPV and accuracy of GeneXpert was 88.6, 93.6, 77.5, 97.0 and 92.6%, respectively.
CONCLUSIONS: GeneXpert is the best available rapid diagnostic method as it can detect MTB and rifampicin resistance gene simultaneously. Accuracy and negative predictive value of GeneXpert was found to be better than AFB staining. Thus, a negative GeneXpert test can rule out TB. Further, a negative GeneXpert and a positive smear microscopy results indicate the presence of NTM. However, GeneXpert is expensive and needs sophisticated instrument when compared to smear microscopy. GERMS.

Entities:  

Keywords:  GeneXpert; Mycobacterium tuberculosis; Tuberculosis; culture; molecular diagnostic method; non-tuberculous mycobacteria; staining

Year:  2020        PMID: 32656104      PMCID: PMC7330512          DOI: 10.18683/germs.2020.1188

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  18 in total

1.  Counts of viable tubercle bacilli in sputum related to smear and culture gradings.

Authors:  B W Allen; D A Mitchison
Journal:  Med Lab Sci       Date:  1992-06

Review 2.  Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance.

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

3.  Comparative Study of GeneXpert with ZN Stain and Culture in Samples of Suspected Pulmonary Tuberculosis.

Authors:  Monika Agrawal; Ashish Bajaj; Vinay Bhatia; Sarjana Dutt
Journal:  J Clin Diagn Res       Date:  2016-05-01

4.  Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology.

Authors:  Soumitesh Chakravorty; Manas Kamal Sen; Jaya Sivaswami Tyagi
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens.

Authors:  Maya Habous; Maimona Ahmed E Elimam; Rajesh Kumar; Zulfa A L Deesi
Journal:  Int J Mycobacteriol       Date:  2019 Apr-Jun

6.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

7.  Comparison of fluorescence microscopy and Ziehl-Neelsen technique in diagnosis of tuberculosis in paediatric patients.

Authors:  Humera Javed; Aizza Zafar; Atiqa Qayyum; Abdur Rehman; Hasan Ejaz
Journal:  J Pak Med Assoc       Date:  2015-08       Impact factor: 0.781

8.  Performance evaluation of the Xpert MTB/RIF assay according to its clinical application.

Authors:  Hee Jae Huh; Byeong-Ho Jeong; Kyeongman Jeon; Won-Jung Koh; Chang-Seok Ki; Nam Yong Lee
Journal:  BMC Infect Dis       Date:  2014-11-14       Impact factor: 3.090

9.  Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Authors:  Nicolas A Menzies; Ted Cohen; Hsien-Ho Lin; Megan Murray; Joshua A Salomon
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069

10.  Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.

Authors:  Ping Zhao; Fang Fang; Qin Yu; Jiao Guo; Jian-Hua Zhang; Jifu Qu; Yingjie Liu
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more
  1 in total

1.  GeneXpert MTB/RIF combined with conventional methods for tuberculosis in Shanghai Regional Medical Center: a retrospective diagnostic study.

Authors:  Huanhuan Zhang; Hong Li; Meiyu Tan; Zhenhao Liu; Jie Gu; Yi Zhang; Huiming Sheng
Journal:  Ann Transl Med       Date:  2022-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.